JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
NCT: NCT05064540 · RECRUITING
広告
NCT識別子NCT05064540
ステータスRECRUITING
開始日2021-09-20
SponsorEndologix (INDUSTRY)
First posted
Last updated
概要
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。